Regenxbio Is A Clinical Stage Biotechnology Company Based In Rockvillemarylandfounded In 2008The Company Focuses On Developing Gene Therapy Technologies Aimed At Improving Lives By Addressing Genetic Defectsits Proprietary Nav Technology Platform Utilizes Recombinant Adeno Associated Virusaavvectors To Deliver Genes To Cellspotentially Altering The Course Of Various Diseases The Company Has A Diverse Product Pipeline That Includes Treatments For Retinalmetabolicand Neurodegenerative Diseasesin Addition To Its Internal Development Effortsregenxbio Licenses Its Nav Vectors To Other Biotechnology Companiesenhancing The Reach And Impact Of Its Gene Therapy Solutionsthrough Strategic Partnerships With Key Players In The Biopharmaceutical Industryregenxbio Leverages Expertise To Drive Innovation And Accelerate The Development Of Its Therapiesthe Company Is Dedicated To Advancing Gene Therapy And Bringing Effective Treatments To Patients
